SANA logo

SANA
Sana Biotechnology Inc

4,151
Mkt Cap
$936.7M
Volume
1.64M
52W High
$6.55
52W Low
$1.60
PE Ratio
-3.59
SANA Fundamentals
Price
$3.51
Prev Close
$3.50
Open
$3.45
50D MA
$3.33
Beta
2.03
Avg. Volume
3.59M
EPS (Annual)
-$0.9642
P/B
5.82
Rev/Employee
$0.00
$966.95
Loading...
Loading...
News
all
press releases
Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3% - Time to Sell?
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 7.3% - Here's What Happened...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell
Wall Street Zen lowered Sana Biotechnology from a "sell" rating to a "strong sell" rating in a research note on Saturday...
MarketBeat·16d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - What's Next?
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - Here's Why...
MarketBeat·20d ago
News Placeholder
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts
Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com...
MarketBeat·23d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - What's Next?
Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - Here's What Happened...
MarketBeat·26d ago
News Placeholder
Baillie Gifford & Co. Sells 4,827,438 Shares of Sana Biotechnology, Inc. $SANA
Baillie Gifford & Co. lessened its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the...
MarketBeat·27d ago
News Placeholder
Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday
Stock futures mixed, Citigroup and Wells Fargo report earnings, Sana Biotechnology announces collaboration.read more...
Benzinga·27d ago
News Placeholder
SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?
Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.
Stocktwits·27d ago
News Placeholder
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines PR Newswire VANCOUVER, BC, April 6, 2026 Issued on behalf...
PR Newswire·1mo ago
News Placeholder
JPMorgan Chase & Co. Raises Holdings in Sana Biotechnology, Inc. $SANA
JPMorgan Chase & Co. lifted its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 180.8% during the third quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·1mo ago
<
1
2
...
>

Latest SANA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.